Service Properties Trust announces 5-for-1 reverse stock split
Get Alerts SVC Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.5%
Revenue Growth %: -19.8%
Join SI Premium – FREE
Service Properties Trust (Nasdaq: SVC) said its Board of Trustees has approved a five-for-one reverse split of its issued and outstanding common shares, anticipated to take effect after the close of trading on or about July 6, 2026, subject to regulatory approvals.
Under the terms of the reverse split, every five shares of SVC common stock will be reclassified into one share, reducing the total number of outstanding shares from approximately 647.7 million to approximately 129.5 million.
The company said the split will affect all shareholders proportionally and will not change any shareholder's ownership percentage, except for minor adjustments resulting from cash payments in lieu of fractional shares. SVC's common shares will continue trading on the Nasdaq Stock Market under the ticker symbol "SVC," though with a new CUSIP number of 81761L 201.
SVC said its regular quarterly cash distribution is expected to remain at $0.05 per share, or $0.20 per share annually, after giving effect to the reverse split. The company noted the distribution rate is subject to approval by its Board of Trustees and may change in the future.
The reverse split is contingent on Nasdaq approval and other customary conditions. Shareholders requiring assistance are directed to contact their broker or SVC's transfer agent, Equiniti Trust Company, LLC.
Service Properties Trust is a real estate investment trust with holdings in service-focused retail net lease properties and hotels. As of March 31, 2026, SVC owned 761 retail net lease properties and 93 hotels across the United States, Puerto Rico, and Canada. The trust is managed by The RMR Group (Nasdaq: RMR).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- Larimar Therapeutics to host investor event on June 29
- FDA approves AbbVie's Skyrizi for children with psoriatic disease
Create E-mail Alert Related Categories
Corporate News, Stock SplitsRelated Entities
Dividend, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share